1-5 of 5
Anthony S Masaquel, PhD MPH
Close
Sort by
Journal Articles

Patient-Reported Disease Burden and Age: Results from a National Patient Advocacy Survey of Patients with Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Keith L. Dawson, DNP, MS, Mark A. Price, MA, MD, Peggy Ann Torney, MS, Victor Gonzalez, MA, MS, Maria Sae-Hau, PhD, Elisa S. Weiss, PhD, Brennan Mange, BA, Carol Mansfield, PhD, Eydith J Comenencia-Ortiz, PhD, Anthony S Masaquel, PhD MPH, Arliene Ravelo, MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 4778.
https://doi.org/10.1182/blood-2019-123644
Published: 2019
Journal Articles

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Ahmad S Halwani, MD, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, MS, Catherine Li, PhD, Zachary R Burningham, PhD, Anthony S Masaquel, PhD MPH, Mary Halloran, PharmD, BCPS, Elisha Delong-Sieg, PharmD, Mathias Schulz, MD MBA, Jia Li, PhD, Brian C Sauer, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1622.
https://doi.org/10.1182/blood-2019-127719
Published: 2019
Journal Articles

Health Resource Utilization and Costs Associated with the Use of Obinutuzumab-Based Regimens Are Similar to Rituximab-Based Regimens for the First-Line Treatment of Follicular Lymphoma

Tu My To, PhD, Keith L. Dawson, DNP, MS, Anthony S Masaquel, PhD MPH, Arpamas Seetasith, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4721.
https://doi.org/10.1182/blood-2019-123408
Published: 2019
Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Alexey Danilov, MD PhD, Habte A Yimer, MD, Michael Boxer, MD, John M Burke, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Peter C Trask, PhD MPH, Anthony S Masaquel, PhD MPH, Jeff P. Sharman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3491.
https://doi.org/10.1182/blood-2019-123630
Published: 2019
Journal Articles

Patterns of Ibrutinib Use, Discontinuation, and Hospitalization Among Patients with Chronic Lymphocytic Leukemia (CLL) in a US Healthcare Claims Database

Tu My To, PhD MPH, Wei-Shi Yeh, PhD MS, Juliana Biondo, Anthony S Masaquel, PhD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 5909.
https://doi.org/10.1182/blood-2018-99-112679
Published: 2018